The FDA has identified increased mortality rates linked to two CAR-T therapies: Carvykti, made by Janssen Biotech, and Abecma, from Bristol-Myers Squibb K.K.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA concerns grow over 2 CAR-T therapies
